MedPath

Effect of supplementation in treatment of gestational diabetes

Not Applicable
Conditions
Gestational diabetes.
Diabetes mellitus in pregnancy, unspecified
O24.9
Registration Number
IRCT201406305623N20
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
54
Inclusion Criteria

Pregnant women aged 18-40 years diagnosed with GDM at 24-28 weeks' gestation

Exclusion Criteria

Pre-existing diabetes
Required complex diets
Chronic medical conditions
Significant psychiatric disease
Smokers
Kidney or liver diseases
Chronic hypertension
Hypothyroidism

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Infants' weight. Timepoint: Delivery time. Method of measurement: Scale.;Infants' head circumference. Timepoint: Delivery time. Method of measurement: Tape.;Newborns' length. Timepoint: Delivery time. Method of measurement: Tape.;Polyhydramnios. Timepoint: After the intervention. Method of measurement: Sonography.;Newborn's bilirubin. Timepoint: Delivery time. Method of measurement: Enzymatic kit.;Apgar score. Timepoint: Delivery time. Method of measurement: Clinical observation.;Preterm delivery. Timepoint: After delivery. Method of measurement: Medical record.;Maternal pre-eclampsia. Timepoint: After delivery. Method of measurement: Medical record.;Maternal hospitalization. Timepoint: After delivery. Method of measurement: Medical record.
Secondary Outcome Measures
NameTimeMethod
Hs-CRP. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: ELISA kit.;Nitric oxide. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.;Total antioxidant. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.;Malondialdehyde. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.;Glutathione. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Spectrophotometry.
© Copyright 2025. All Rights Reserved by MedPath